Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Specific targeting of lung ILC2s via NRP1 in pulmonary fibrosis

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1

References

  1. Zheng H, Zhang Y, Pan J, Liu N, Qin Y, Qiu L, et al. The role of type 2 innate lymphoid cells in allergic diseases. Front Immunol. 2021;12:586078.

    CAS  Article  Google Scholar 

  2. Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate lymphoid cells in autoimmune diseases. Front Immunol. 2021;12:789788.

    CAS  Article  Google Scholar 

  3. Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells: 10 years on. Cell 2018;174:1054–66.

    CAS  Article  Google Scholar 

  4. Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, et al. Dysregulated expression of the nuclear exosome targeting complex component Rbm7 in nonhematopoietic cells licenses the development of fibrosis. Immunity 2020;52:542–56.

    CAS  Article  Google Scholar 

  5. Satoh T, Nakagawa K, Sugihara F, Kuwahara R, Ashihara M, Yamane F, et al. Identification of an atypical monocyte and committed progenitor involved in fibrosis. Nature 2017;541:96–101.

    CAS  Article  Google Scholar 

  6. Zhang J, Qiu J, Zhou W, Cao J, Hu X, Mi W, et al. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat Immunol. 2022;23:237–50.

    Article  Google Scholar 

  7. Ricardo-Gonzalez RR, Van Dyken SJ, Schneider C, Lee J, Nussbaum JC, Liang HE, et al. Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol. 2018;19:1093–9.

    CAS  Article  Google Scholar 

  8. Mazzurana L, Czarnewski P, Jonsson V, Wigge L, Ringner M, Williams TC, et al. Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing. Cell Res. 2021;31:554–68.

    CAS  Article  Google Scholar 

  9. Nakatsuka Y, Yaku A, Handa T, Vandenbon A, Hikichi Y, Motomura Y, et al. Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1. Eur Respir J. 2021;57:2000018.

  10. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103:779–88.

    CAS  Article  Google Scholar 

  11. Wijsenbeek MS, Kool M, Cottin V. Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end. Eur Respir J. 2018;52:1802111.

Download references

Acknowledgements

We thank Susan Zunino, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Funding

This work was supported, in part, by AMED (grant numbers JP20fk0108129, JP21fk0108129h0702, and JP21lm0203007), a GSK Research grant (grant number A-32), JSPS KAKENHI (grant numbers JP21K16118 and JP21K08194), the Smoking Research Foundation (grant number 2021Y007), the Takeda Science Foundation, the Uehara Memorial Foundation (grant number 202110055), the MSD Life Science Foundation (grant number RA-026), the Japanese Respiratory Society Boehringer Ingelheim Research Grant Program, and the Japan Intractable Diseases (Nanbyo) Research Foundation (grant number 2020B02).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Kida.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests. The funders had no role in the writing of the manuscript or in the decision to publish the results.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nii, T., Fukushima, K. & Kida, H. Specific targeting of lung ILC2s via NRP1 in pulmonary fibrosis. Cell Mol Immunol 19, 869–871 (2022). https://doi.org/10.1038/s41423-022-00867-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-022-00867-0

Search

Quick links